Year |
Citation |
Score |
2020 |
Dong Y, Cao H, Cao R, Baranova A. TNFRSF12A and CD38 Contribute to a Vicious Circle for Chronic Obstructive Pulmonary Disease by Engaging Senescence Pathways. Frontiers in Cell and Developmental Biology. 8: 330. PMID 32537452 DOI: 10.3389/Fcell.2020.00330 |
0.315 |
|
2020 |
Zhang XJ, Cui ZH, Dong Y, Liang XW, Zhao YX, Baranova A, Cao H, Wang L. GPNMB contributes to a vicious circle for chronic obstructive pulmonary disease. Bioscience Reports. PMID 32478378 DOI: 10.1042/Bsr20194459 |
0.301 |
|
2018 |
Turchinovich A, Baranova A, Drapkina O, Tonevitsky A. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in Physiology. 9: 1256. PMID 30294278 DOI: 10.3389/Fphys.2018.01256 |
0.401 |
|
2018 |
Baranova A, Maltseva D, Tonevitsky A. Adipose may actively delay progression of NAFLD by releasing tumor-suppressing, anti-fibrotic miR-122 into circulation. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. 20: 108-118. PMID 30248223 DOI: 10.1111/Obr.12765 |
0.356 |
|
2018 |
Mehta R, Shaw G, Masschelin P, Felix S, Otgonsuren M, Baranova A, Goodman Z, Younossi Z. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). Plos One. 13: e0199294. PMID 29928018 DOI: 10.1371/Journal.Pone.0199294 |
0.717 |
|
2018 |
Poloznikov A, Gazaryan I, Shkurnikov M, Nikulin S, Drapkina O, Baranova A, Tonevitsky A. In vitro and in silico liver models: Current trends, challenges and opportunities. Altex. PMID 29813171 DOI: 10.14573/Altex.1803221 |
0.347 |
|
2017 |
Mayburd A, Baranova A. Knowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms for a Complex Disease. Methods in Molecular Biology (Clifton, N.J.). 1613: 425-461. PMID 28849571 DOI: 10.1007/978-1-4939-7027-8_17 |
0.316 |
|
2017 |
Zolotarenko A, Chekalin E, Mehta R, Baranova A, Tatarinova TV, Bruskin S. Identification of Transcriptional Regulators of Psoriasis from RNA-Seq Experiments. Methods in Molecular Biology (Clifton, N.J.). 1613: 355-370. PMID 28849568 DOI: 10.1007/978-1-4939-7027-8_14 |
0.656 |
|
2016 |
Zolotarenko A, Chekalin E, Mesentsev A, Kiseleva L, Gribanova E, Mehta R, Baranova A, Tatarinova TV, Piruzian ES, Bruskin S. Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis. Experimental & Molecular Medicine. 48: e268. PMID 27811935 DOI: 10.1038/Emm.2016.97 |
0.663 |
|
2016 |
Mehta R, Jeiran K, Koenig AB, Otgonsuren M, Goodman Z, Baranova A, Younossi Z. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). Bmc Medical Genetics. 17: 63. PMID 27596100 DOI: 10.1186/S12881-016-0324-0 |
0.738 |
|
2016 |
Birerdinc A, Marzouk M, Loria A, Wang L, De Avila L, Baranova A, Younossi ZM. Tu1676 A Meta-Analysis of the Global Prevalence of Hepatitis B in Light of Increasing HBV Vaccination: Is There Any Change? Gastroenterology. 150: S1164-S1165. DOI: 10.1016/S0016-5085(16)33933-6 |
0.592 |
|
2016 |
Orciga MP, Younoszai Z, Yao K, Keaton M, Baranova A, Birerdinc A, Younossi ZM. Su1961 The Role of Insulin-like Growth Factor 1 (IGF1) in Polycystic Ovarian Syndrome in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 150: S599-S600. DOI: 10.1016/S0016-5085(16)32060-1 |
0.681 |
|
2015 |
Manyam G, Birerdinc A, Baranova A. KPP: KEGG Pathway Painter. Bmc Systems Biology. 9: S3. PMID 25879163 DOI: 10.1186/1752-0509-9-S2-S3 |
0.697 |
|
2015 |
Stepanova M, Rodriguez E, Birerdinc A, Baranova A. Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity. Oncotarget. 6: 1414-21. PMID 25638154 DOI: 10.18632/Oncotarget.2725 |
0.625 |
|
2015 |
Estep JM, Goodman Z, Sharma H, Younossi E, Elarainy H, Baranova A, Younossi Z. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 1367-72. PMID 24684403 DOI: 10.1111/Liv.12555 |
0.742 |
|
2015 |
Jeiran K, Mehta R, Otgonsuren M, Koenig AB, Goodman ZD, Baranova A, Younossi ZM. Su1797 Mitochondrial DNA Polymorphisms and Protection Against Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 148: S-1053. DOI: 10.1016/S0016-5085(15)33594-0 |
0.726 |
|
2014 |
Veytsman B, Wang L, Cui T, Bruskin S, Baranova A. Distance-based classifiers as potential diagnostic and prediction tools for human diseases. Bmc Genomics. 15: S10. PMID 25563076 DOI: 10.1186/1471-2164-15-S12-S10 |
0.314 |
|
2014 |
Mehta R, Neupane A, Wang L, Goodman Z, Baranova A, Younossi ZM. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. Bmc Gastroenterology. 14: 208. PMID 25512222 DOI: 10.1186/S12876-014-0208-8 |
0.753 |
|
2014 |
Mehta R, Birerdinc A, Wang L, Younoszai Z, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. Bmc Gastroenterology. 14: 72. PMID 24716593 DOI: 10.1186/1471-230X-14-72 |
0.816 |
|
2014 |
Glebova K, Reznik ON, Reznik AO, Mehta R, Galkin A, Baranova A, Skoblov M. siRNA technology in kidney transplantation: current status and future potential. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 28: 345-61. PMID 24573958 DOI: 10.1007/S40259-014-0087-0 |
0.632 |
|
2014 |
Loria A, Doyle K, Weinstein AA, Winter P, Escheik C, Price J, Wang L, Birerdinc A, Baranova A, Gerber L, Younossi ZM. Multiple factors predict physical performance in people with chronic liver disease. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 93: 470-6. PMID 24398583 DOI: 10.1097/Phm.0000000000000050 |
0.66 |
|
2014 |
Birerdinc A, Keaton M, Doyle K, Younoszai Z, Wang L, Goodman Z, Baranova A, Younossi Z. IL-8 Is an Important Contributor to Both the Progression of Systematic Inflammation and Increasing Severity of Non-Alcoholic Fatty Liver Disease (NAFLD) American Journal of Gastroenterology. 109: S168. DOI: 10.14309/00000434-201410002-00575 |
0.693 |
|
2014 |
Tavakolian K, Estep J, Baranova A, Goodman Z, Younossi Z. Adiponectin Ligand and Receptor Expression in Omental Adipose Tissue of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) American Journal of Gastroenterology. 109: S168. DOI: 10.14309/00000434-201410002-00574 |
0.763 |
|
2014 |
Doyle K, Keaton M, Wang L, Mehta R, Abawi M, Younoszai Z, Jeffers T, Elarainy HA, Moazez AH, Birerdinc A, Baranova A, Younossi ZM. Tu2019 Role of Vitamin D in the Inflammatory Response of Morbidly Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 146: S-900. DOI: 10.1016/S0016-5085(14)63272-8 |
0.733 |
|
2014 |
Keaton M, Doyle K, Wang L, Mehta R, Younoszai Z, Birerdinc A, Elarainy HA, Baranova A, Younossi ZM. Mo1776 Potential Factors Involved in the Differentiation of Bat From Wat in Morbidly Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 146: S-657. DOI: 10.1016/S0016-5085(14)62392-1 |
0.781 |
|
2013 |
Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A, Mehta R, Chandhoke V, Birerdinc A, Younossi ZM. Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). Journal of Translational Medicine. 11: 133. PMID 23721173 DOI: 10.1186/1479-5876-11-133 |
0.819 |
|
2013 |
Sharma H, Estep M, Birerdinc A, Afendy A, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 28: 1410-5. PMID 23663110 DOI: 10.1111/Jgh.12268 |
0.653 |
|
2013 |
Mehta R, Birerdinc A, Neupane A, Shamsaddini A, Afendy A, Elariny H, Chandhoke V, Baranova A, Younossi ZM. Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. Mediators of Inflammation. 2013: 684237. PMID 23661906 DOI: 10.1155/2013/684237 |
0.806 |
|
2013 |
Skoblov M, Marakhonov A, Marakasova E, Guskova A, Chandhoke V, Birerdinc A, Baranova A. Protein partners of KCTD proteins provide insights about their functional roles in cell differentiation and vertebrate development. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 35: 586-96. PMID 23592240 DOI: 10.1002/Bies.201300002 |
0.587 |
|
2013 |
Page S, Birerdinc A, Estep M, Stepanova M, Afendy A, Petricoin E, Younossi Z, Chandhoke V, Baranova A. Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example. Plos One. 8: e56009. PMID 23405244 DOI: 10.1371/Journal.Pone.0056009 |
0.758 |
|
2013 |
Birerdinc A, Jarrar M, Stotish T, Randhawa M, Baranova A. Manipulating molecular switches in brown adipocytes and their precursors: a therapeutic potential. Progress in Lipid Research. 52: 51-61. PMID 22960032 DOI: 10.1016/J.Plipres.2012.08.001 |
0.778 |
|
2013 |
Loria A, Doyle K, Weinstein A, Winter P, Escheik C, Price J, Shrestha A, Wang L, Birerdinc A, Baranova A, Gerber L, Younossi Z. Resting Heart Rate and Fasting Glucose Predict Physical Performance in People with Chronic Liver Disease American Journal of Gastroenterology. 108: S123. DOI: 10.14309/00000434-201310001-00413 |
0.624 |
|
2013 |
Doyle K, Birerdinc A, Wang L, Mehta R, Koob C, Sok S, Younoszai Z, Chandhoke V, Baranova A, Younossi Z. TGF-Beta-Guided Inflammatory Signaling Originating in Visceral Adipose Tissue Is Intrinsically Involved in the Etiology of Depression in Obese Patients with Non-alcoholic Fatty Liver Disease (NAFLD) American Journal of Gastroenterology. 108: S118. DOI: 10.14309/00000434-201310001-00392 |
0.809 |
|
2013 |
Mehta R, Keaton M, Doyle K, Wang L, Birerdinc A, Goodman Z, Baranova A, Younossi Z. 1310 EXPRESSION AND SYSTEMS BIOLOGY ANALYSIS OF T-CELL AND MACROPHAGE SPECIFIC FACTORS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Journal of Hepatology. 58: S529. DOI: 10.1016/S0168-8278(13)61311-2 |
0.703 |
|
2013 |
Birerdinc A, Doyle K, Wang L, Dadkhah E, Mehta R, Afendy A, Baranova A, Goodman Z, Younossi ZM. Mo1047 The Adipocyte-Derived PRO-Inflammatory and Fibrogenic Factors Differentially Influence Individual Pathogenetic Components of Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-1021-S-1022. DOI: 10.1016/S0016-5085(13)63793-2 |
0.807 |
|
2013 |
Doyle K, Birerdinc A, Wang L, Mehta R, Younoszai Z, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Tu2041 The Levels of TGFβ1 Production in Adipose Indicate the Complexity of the Relationship Between Depression and Anxiety Disorders in Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-910-S-911. DOI: 10.1016/S0016-5085(13)63397-1 |
0.803 |
|
2013 |
Birerdinc A, Mehta R, Doyle K, Wang L, Keskin T, Younoszai Z, Baranova A, Elariny HA, Moazzez AH, Younossi ZM. Tu1747 MRNAs for Ucp1 and PRDM16 Are Detectable in Visceral Adipose of Obese Subjects Indicating Therapeutic Trans-Differentiation Potential Gastroenterology. 144: S-836. DOI: 10.1016/S0016-5085(13)63110-8 |
0.765 |
|
2013 |
Abawi M, Birerdinc A, Wang L, Doyle K, Afendy A, Elariny HA, Chandhoke V, Baranova A, Younossi ZM. Mo2113 The Hormonal Regulation of Vitamin D Metabolism Is Substantially Modified in Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-745-S-746. DOI: 10.1016/S0016-5085(13)62765-1 |
0.708 |
|
2013 |
Mehta R, Keaton M, Wang L, Birerdinc A, Doyle K, Baranova A, Moazzez AH, Elariny HA, Younossi ZM. 396 The Balance of T-Lymphocyte Specifying Transcription Factors and the Cytokine Expression in Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-77. DOI: 10.1016/S0016-5085(13)60281-4 |
0.817 |
|
2012 |
Birerdinc A, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM. Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C). Brain and Behavior. 2: 525-31. PMID 23139898 DOI: 10.1002/Brb3.72 |
0.602 |
|
2012 |
Birerdinc A, Mehta R, Alhussain R, Afendi A, Chandhoke V, Younossi Z, Baranova A. [Selection of reliable reference genes for qRT-PCR analysis in human non-cancerous gastric tissue]. Molekuliarnaia Biologiia. 46: 166-75. PMID 22642115 DOI: 10.1134/S0026893312010049 |
0.77 |
|
2012 |
Mehta R, Baranova A, Birerdinc A. Do-It-Yourself device for recovery of cryopreserved samples accidentally dropped into cryogenic storage tanks. Journal of Visualized Experiments : Jove. e3903. PMID 22617806 DOI: 10.3791/3903 |
0.727 |
|
2012 |
Birerdinc A, Estep M, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM. Gene expression profiles associated with anaemia and ITPA genotypes in patients with chronic hepatitis C (CH-C). Journal of Viral Hepatitis. 19: 414-22. PMID 22571903 DOI: 10.1111/J.1365-2893.2011.01564.X |
0.635 |
|
2012 |
Stephen S, Baranova A, Younossi ZM. Nonalcoholic fatty liver disease and bariatric surgery. Expert Review of Gastroenterology & Hepatology. 6: 163-71. PMID 22375522 DOI: 10.1586/Egh.11.97 |
0.406 |
|
2012 |
Younossi ZM, Birerdinc A, Estep M, Stepanova M, Afendy A, Baranova A. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Journal of Translational Medicine. 10: 25. PMID 22313623 DOI: 10.1186/1479-5876-10-25 |
0.62 |
|
2012 |
Elariny HA, Baranova A. Comment on: Diet-induced obesity associated with steatosis, oxidative stress and inflammation in liver. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 8: 81-3. PMID 22118841 DOI: 10.1016/J.Soard.2011.10.004 |
0.368 |
|
2012 |
Estep MJ, Matharoo G, Hossain N, Nguyenngo C, Goodman Z, Baranova A, Younossi Z. Elevated Fasting Serum Glucose in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients is Correlated with the Degree of Steatosis American Journal of Gastroenterology. 107: S166. DOI: 10.14309/00000434-201210001-00393 |
0.441 |
|
2012 |
Abawi M, Wang L, Hashemi M, Birerdinc A, Chandhoke V, Baranova A, Younossi Z. Vitamin D and PTH Levels in Morbidly Obese Patients With and Without Chronic Liver Disease American Journal of Gastroenterology. 107: S160. DOI: 10.14309/00000434-201210001-00376 |
0.67 |
|
2012 |
Birerdinc A, Abawi M, Stepanova M, Afendy A, Baranova A, Goodman Z, Younossi Z. 1269 VITAMIN D MAY BE PROTECTIVE AGAINST APOPTOSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) Journal of Hepatology. 56: S501-S502. DOI: 10.1016/S0168-8278(12)61281-1 |
0.633 |
|
2012 |
Estep J, Goodman Z, Zirzow A, Afendy A, Elariny H, Baranova A, Younossi Z. 1268 DIFFERENTIAL EXPRESSION OF HEPATIC FAS AND ITS LIGAND FASLG EXPRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Journal of Hepatology. 56: S501. DOI: 10.1016/S0168-8278(12)61280-X |
0.747 |
|
2012 |
Birerdinc A, Estep JM, Mehta R, Wang L, Afendy A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Tu1816 Multi-System Analysis of the Inflammatory-Immunomodulatory-Obesity Axis in Non-Alcoholic Liver Disease (NAFLD) Gastroenterology. 142: S-1024. DOI: 10.1016/S0016-5085(12)63962-6 |
0.827 |
|
2012 |
Estep JM, Stepanova M, Afendy A, Petricoin E, Baranova A, Younossi ZM. Sa1089 Proteomic Analysis of ITPA SNP rs1127354 Chronic Hepatitis C (Ch-C) Patients Indicates Differential Regulation of Apoptosis Pathway Components Gastroenterology. 142: S-966. DOI: 10.1016/S0016-5085(12)63742-1 |
0.669 |
|
2012 |
Nguyenngo CT, Estep JM, Stepanova M, Afendy M, Goodman Z, Baranova A, Younossi ZM. Su1956 Clinical and Metabolic Profile of Morbidly Obese Patients With Non-Alcoholic Steatohepatitis (NASH) Gastroenterology. 142: S-545. DOI: 10.1016/S0016-5085(12)62095-2 |
0.718 |
|
2012 |
Baranova A, Abawi M, Wang L, Goodman Z, Chandhoke V, Estep JM, Younossi ZM. Su1955 Alpha Melanocyte-Stimulating Hormone (MSH), Melanin-Concentrating Hormone (MCH), and Obestatin are Associated With Hepatic Inflammation in Morbidly Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients Gastroenterology. 142: S-545. DOI: 10.1016/S0016-5085(12)62094-0 |
0.726 |
|
2012 |
Birerdinc A, Abawi M, Stepanova M, Afendy A, Baranova A, Younossi ZM. 828 Vitamin D Levels Significantly Correlate With Marker of Apoptosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 142: S-143-S-144. DOI: 10.1016/S0016-5085(12)60540-X |
0.69 |
|
2011 |
Baranova A, Lal P, Birerdinc A, Younossi ZM. Non-invasive markers for hepatic fibrosis. Bmc Gastroenterology. 11: 91. PMID 21849046 DOI: 10.1186/1471-230X-11-91 |
0.667 |
|
2011 |
Estep M, Abawi M, Jarrar M, Wang L, Stepanova M, Elariny H, Moazez A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obesity Surgery. 21: 1750-7. PMID 21744131 DOI: 10.1007/S11695-011-0475-1 |
0.807 |
|
2011 |
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics. 34: 274-85. PMID 21623852 DOI: 10.1111/J.1365-2036.2011.04724.X |
0.466 |
|
2011 |
Baranova A, Bode J, Manyam G, Emelianenko M. An efficient algorithm for systematic analysis of nucleotide strings suitable for siRNA design. Bmc Research Notes. 4: 168. PMID 21619643 DOI: 10.1186/1756-0500-4-168 |
0.56 |
|
2011 |
Baranova A, Tran TP, Birerdinc A, Younossi ZM. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 33: 801-14. PMID 21251033 DOI: 10.1111/J.1365-2036.2011.04579.X |
0.637 |
|
2011 |
Younossi ZM, Limongi D, Stepanova M, Pierobon M, Afendy A, Mehta R, Baranova A, Liotta L, Petricoin E. Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV). Journal of Proteome Research. 10: 774-9. PMID 21204552 DOI: 10.1021/Pr100923U |
0.66 |
|
2011 |
Baranova A, Jarrar MH, Stepanova M, Johnson A, Rafiq N, Gramlich T, Chandhoke V, Younossi ZM. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C. Digestion. 83: 32-40. PMID 20847561 DOI: 10.1159/000314592 |
0.745 |
|
2011 |
Page S, Chandhoke V, Baranova A. Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation? Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. 12: e21-31. PMID 20576005 DOI: 10.1111/J.1467-789X.2010.00773.X |
0.666 |
|
2011 |
Younossi ZM, Page S, Rafiq N, Birerdinc A, Stepanova M, Hossain N, Afendy A, Younoszai Z, Goodman Z, Baranova A. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obesity Surgery. 21: 431-9. PMID 20532833 DOI: 10.1007/S11695-010-0204-1 |
0.778 |
|
2011 |
Page S, Estep M, Afendy A, Birerdinc A, Petricoin E, Baranova A, Younossi Z. CCL-2 and Soluble Fas Ligand as Markers of Hepatic Fibrosis in Patients with Non-alcoholic Fatty Liver Disease (NAFLD) American Journal of Gastroenterology. 106: S131. DOI: 10.14309/00000434-201110002-00331 |
0.709 |
|
2011 |
Abawi M, Birerdinc A, Baranova A, Afendy A, Page S, Stepanova M, Goodman Z, Younossi Z. Vitamin D Levels in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients Correlate with Apoptosis and Serum Levels of M30 American Journal of Gastroenterology. 106: S121. DOI: 10.14309/00000434-201110002-00304 |
0.675 |
|
2011 |
Younossi Z, Baranova A, Abawi M, Afendy A, Mehta R, Stepanova M, Goodman Z, Chandhoke V, Birerdinc A. Vitamin D Level in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients Remains Deficient Despite Multivitamin Supplementation American Journal of Gastroenterology. 106: S120. DOI: 10.14309/00000434-201110002-00301 |
0.795 |
|
2011 |
Birerdinc A, Lei W, Ozcan K, Nguyenngo C, Estep M, Afendy A, Baranova A, Younossi Z. Aminotransferse Levels are not Predictive of Histologic Activity or Stage in Morbidly Obese Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH) American Journal of Gastroenterology. 106: S116-S117. DOI: 10.14309/00000434-201110002-00294 |
0.714 |
|
2011 |
Birerdinc A, Estep M, Afendy A, Younossi I, Stepanova M, Baranova A, Younossi Z. The Pre-treatment Gene Expression Profile of Chronic Hepatitis C (CH-C) Patients with IL28B T* Host Genotype and HCV Genotype 1 (G1) Suggest an Intrinsic Deregulation in the Inflammatory Response Mechanism American Journal of Gastroenterology. 106: S116. DOI: 10.14309/00000434-201110002-00293 |
0.622 |
|
2011 |
Younossi Z, Estep J, Birerdinc A, Stepanova M, Baranova A, Younossi I, Afendy A. 1352 IL28B-CC GENOTYPE-RELATED GENE EXPRESSION DURING TREATMENT OF CHRONIC HEPATITIS C (CH-C) WITH PEGYLATED INTERFERON-ALFA (PEG-IFN) AND RIBAVIRIN (RBV): POTENTIAL MECHANISMS FOR SUSTAINED VIROLOGIC RESPONSE (SVR) Journal of Hepatology. 54: S534. DOI: 10.1016/S0168-8278(11)61354-8 |
0.779 |
|
2011 |
Birerdinc A, Afendy A, Stepanova M, Younossi I, Manyam G, Baranova A, Younossi Z. 1193 ANTIGEN PROCESSING AND PROTEASOME DEGRADATION PATHWAYS ARE INVOLVED IN PATIENTS WITH CHRONIC HEPATITIS C WITH NEGATIVE PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN (PEG-IFN/RBV) Journal of Hepatology. 54: S471. DOI: 10.1016/S0168-8278(11)61195-1 |
0.725 |
|
2011 |
Estep M, Vernon G, Wang L, Stepanova M, Younoszai A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi Z. 880 SERUM DES-ACYLGHRELIN CONCENTRATION IS ASSOCIATED WITH HISTOLOGIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Journal of Hepatology. 54: S350-S351. DOI: 10.1016/S0168-8278(11)60882-9 |
0.448 |
|
2011 |
Mehta R, Birerdinc A, Wang L, Afendy A, Stepanova M, Elariny HA, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Gastric Gene Expression of Inflammatory Cytokines in Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Gastroenterology. 140: S-985. DOI: 10.1016/S0016-5085(11)64083-3 |
0.808 |
|
2011 |
Estep JM, Sharma H, Vernon GC, Armistead DL, Hossain N, Elariny HA, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression Level of IL20, mTOR, IL13RA1, and SEMA4C Are Increased in the Visceral Adipose Tissue of Patients With Non-Alcoholic Steathepatitis While There is a Decrease in the Expression Levels of Their Regulatory Mirnas Gastroenterology. 140: S-983. DOI: 10.1016/S0016-5085(11)64074-2 |
0.797 |
|
2011 |
Baranova A, Jarrar M, Abawi M, Wang L, Afendy A, Stepanova M, Estep JM, Moazzez AH, Goodman Z, Chandhoke V, Younossi ZM. Soluble Molecules Released From Visceral Adipose Tissue May Contribute to the Development of Advanced Non-Alcoholic Fatty Liver Disease Gastroenterology. 140: S-701. DOI: 10.1016/S0016-5085(11)62914-4 |
0.822 |
|
2011 |
Sharma H, Estep JM, Armistead DL, Vernon GC, Hossain N, Moazzez AH, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression Level for miRNA Processing Enzymes DICER1, RNASEN, and DGCR8 Are Increased in the Visceral Adipose Tissue of Non-Alcoholic Steatohepatitis (NASH) Patients Gastroenterology. 140: S-701. DOI: 10.1016/S0016-5085(11)62912-0 |
0.813 |
|
2011 |
Gerber L, Page S, Price JK, Baranova A, Winter PM, Younossi ZM. Association of Serum Biomarkers With Fatigue in Patients With Chronic Liver Disease Gastroenterology. 140: S-461. DOI: 10.1016/S0016-5085(11)61894-5 |
0.348 |
|
2011 |
Birerdinc A, Mehta R, Wang L, Afendy A, Stepanova M, Elariny HA, Moazzez AH, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of Energy Metabolism Related Genes in the Gastric Tissue of Obese Patients Gastroenterology. 140: S-117. DOI: 10.1016/S0016-5085(11)60474-5 |
0.777 |
|
2011 |
Baranova A, Younossi ZM. Biomarkers for Non-invasive Diagnosis of Non-alcoholic Steatohepatitis Obesity Surgery. 21: 1318-1318. DOI: 10.1007/S11695-011-0467-1 |
0.408 |
|
2010 |
Biderman B, Marakhonov A, Skoblov M, Birerdinc A, Nohelty E, Page S, Khomenkov V, Chandhoke V, Sudarikov A, Nikitin E, Baranova A. Inhibition of potassium currents as a pharmacologic target for investigation in chronic lymphocytic leukemia. Drug News & Perspectives. 23: 625-31. PMID 21180648 DOI: 10.1358/dnp.2010.23.10.1507740 |
0.7 |
|
2010 |
Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, Baranova A, Chandhoke V, Younossi ZM. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 32: 487-97. PMID 20497147 DOI: 10.1111/J.1365-2036.2010.04366.X |
0.456 |
|
2010 |
Mehta R, Birerdinc A, Hossain N, Afendy A, Chandhoke V, Younossi Z, Baranova A. Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. Bmc Molecular Biology. 11: 39. PMID 20492695 DOI: 10.1186/1471-2199-11-39 |
0.789 |
|
2010 |
Younossi ZM, Baranova A, Stepanova M, Page S, Calvert VS, Afendy A, Goodman Z, Chandhoke V, Liotta L, Petricoin E. Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis. Journal of Proteome Research. 9: 3218-24. PMID 20441224 DOI: 10.1021/Pr100069E |
0.643 |
|
2010 |
Birerdinc A, Nohelty E, Marakhonov A, Manyam G, Panov I, Coon S, Nikitin E, Skoblov M, Chandhoke V, Baranova A. Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 31: 33-45. PMID 20237900 DOI: 10.1007/S13277-009-0005-0 |
0.713 |
|
2010 |
Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, Baranova A, Younossi Z. Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. Obesity Surgery. 20: 640-50. PMID 20119733 DOI: 10.1007/S11695-010-0078-2 |
0.476 |
|
2010 |
Birerdinc A, Afendy A, Stepanova M, Younossi I, Manyam G, Baranova A, Younossi ZM. Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C. Journal of Viral Hepatitis. 17: 730-6. PMID 20002302 DOI: 10.1111/J.1365-2893.2009.01235.X |
0.746 |
|
2010 |
Estep J, Stepanova M, Zirzow A, Hossain N, Elarainy H, Baraki Y, Moazzez A, Goodman Z, Chandhoke V, Baranova A, Younossi Z. Baseline Serum Obestatin Correlates with Rate of Weight Loss after Bariatric Surgery American Journal of Gastroenterology. 105: S37-S38. DOI: 10.14309/00000434-201010001-00099 |
0.631 |
|
2010 |
Alhussain R, Mehta R, Birerdinc A, Hossain N, Baraki Y, Elariny H, Chandhoke V, Baranova A, Younossi Z. Profiling and Validation of Reference Genes in the Gastric Tissue of Morbidly Obese Patients American Journal of Gastroenterology. 105: S37. DOI: 10.14309/00000434-201010001-00098 |
0.776 |
|
2010 |
Baranova A, Manyam G, Giuliani A. Abstract 111: Genome-wide expression pattern as a composite biomarker of cancer Cancer Research. 70: 111-111. DOI: 10.1158/1538-7445.Am10-111 |
0.582 |
|
2010 |
Stepanova M, Manyam G, Hossain N, Chandhoke V, Baranova A, Goodman Z, Younossi Z. 805 FUNCTIONAL PATHWAY ANALYSIS OF GENE EXPRESSION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) Journal of Hepatology. 52: S313. DOI: 10.1016/S0168-8278(10)60807-0 |
0.693 |
|
2010 |
Estep J, Armistead D, Stepanova M, Hossain N, Elarainy H, Baranova A, Goodman Z, Chandhoke V, Younossi Z. 79 SERUM CYTOKINES AND THE EXPRESSION OF MIRNAS IN THE VISCERAL ADIPOSE OF PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE Journal of Hepatology. 52: S36. DOI: 10.1016/S0168-8278(10)60081-5 |
0.74 |
|
2010 |
Desai D, Estep M, Birerdinc A, Mir HM, Baranova A, Chandhoke V, Younossi ZM. M1887 Markers of Insulin Resistance During HCV Treatment: A Relationship to Sustained Virologic Response (SVR) Gastroenterology. 138: S-829. DOI: 10.1016/S0016-5085(10)63821-8 |
0.581 |
|
2010 |
Estep M, Abawi M, Bolden S, Stepanova M, Hossain N, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. S1851 Serum Obestatin Concentrations in Non-Alcoholic Fatty Liver Disease (NAFLD) With Fibrosis Gastroenterology. 138: S-802. DOI: 10.1016/S0016-5085(10)63698-0 |
0.442 |
|
2010 |
Mehta R, Birerdinc A, Hossain N, Moazez AH, Chandhoke V, Baranova A, Younossi ZM. W1853 Profiling and Validation of Reference Genes in the Visceral Adipose Tissue (Vat) Gastroenterology. 138: S-753-S-754. DOI: 10.1016/S0016-5085(10)63473-7 |
0.767 |
|
2010 |
Birerdinc A, Mehta R, Hossain N, Baraki Y, Elariny HA, Baranova A, Chandhoke V, Younossi ZM. W1852 Differential Gene Expression Profiling of Brown Adipose Tissue (Bat) Specific Genes in Visceral Adipose Tissue of Lean and Obese Individuals Gastroenterology. 138: S-753. DOI: 10.1016/S0016-5085(10)63472-5 |
0.78 |
|
2010 |
Birerdinc A, Stepanova M, Afendy A, Manyam G, Younossi I, Gramlich T, Baranova A, Younossi ZM. S1256 Up-Regulation of Matrix Metalloproteinase 9 (MMP-9) and Interleukin-8 (IL-8) in African-Americans Patients With Chronic Hepatitis C Gastroenterology. 138: S-214. DOI: 10.1016/S0016-5085(10)60972-9 |
0.712 |
|
2009 |
Manyam G, Baranova A, Skoblov M, Mishra RK. SnS-Align: a graphic tool for alignment of distantly related proteins. International Journal of Bioinformatics Research and Applications. 5: 663-73. PMID 19887339 DOI: 10.1504/Ijbra.2009.029045 |
0.544 |
|
2009 |
Younossi ZM, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, Gramlich T, Baranova A. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C. Liver International : Official Journal of the International Association For the Study of the Liver. 29: 1403-12. PMID 19515216 DOI: 10.1111/J.1478-3231.2009.02060.X |
0.407 |
|
2009 |
Estep JM, Baranova A, Hossain N, Elariny H, Ankrah K, Afendy A, Chandhoke V, Younossi ZM. Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. Obesity Surgery. 19: 617-24. PMID 19280268 DOI: 10.1007/S11695-009-9814-X |
0.761 |
|
2009 |
Younossi ZM, Baranova A, Afendy A, Collantes R, Stepanova M, Manyam G, Bakshi A, Sigua CL, Chan JP, Iverson AA, Santini CD, Chang SY. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin. Hepatology (Baltimore, Md.). 49: 763-74. PMID 19140155 DOI: 10.1002/Hep.22729 |
0.608 |
|
2009 |
Randhawa M, Huff T, Valencia JC, Younossi Z, Chandhoke V, Hearing VJ, Baranova A. Evidence for the ectopic synthesis of melanin in human adipose tissue. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 835-43. PMID 18971261 DOI: 10.1096/Fj.08-116327 |
0.762 |
|
2009 |
Lim HM, Kim ER, Kim JY, Chang DK, Son HJ, Rhee P, Kim JJ, Rhee JC, Kim Y, Nass FR, Kotze LMdS, Biecker E, Hausdörfer I, Grünhage F, Strunk H, ... ... Baranova A, et al. JGA Society News Digestion. 80: 136-136. DOI: 10.1159/000232948 |
0.69 |
|
2009 |
Baranova A, Kaur I, Hossain N, Randhawa M, Chandhoke V, Younossi Z. 1035 DIFFERENCES OF ADIPOCYTOKINE BETWEEN NON- ALCOHOLIC FATTY LIVER DISEASE AND CORONARY ARTERY DISEASE Journal of Hepatology. 50: S374. DOI: 10.1016/S0168-8278(09)61037-0 |
0.781 |
|
2009 |
Younossi Z, Baranova A, Stepanova M, Calvert V, Afendy A, Goodman Z, Liotta L, Petrocoins E. 730 PROTEOMICS BIOMARKERS PREDICTING HISTOLOGIC NON-ALCOHOLIC STEATOHEAPTITIS AND FIBROSIS Journal of Hepatology. 50: S266-S267. DOI: 10.1016/S0168-8278(09)60732-7 |
0.357 |
|
2008 |
Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obesity Surgery. 18: 1430-7. PMID 18500507 DOI: 10.1007/S11695-008-9506-Y |
0.815 |
|
2008 |
Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Adipokines and cytokines in non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 27: 412-21. PMID 18081738 DOI: 10.1111/J.1365-2036.2007.03586.X |
0.795 |
|
2008 |
Alsheddi T, Vasin L, Meduri R, Randhawa M, Glazko G, Baranova A. siRNAs with high specificity to a target: A systematic design by the CRM algorithm Molecular Biology. 42: 146-152. DOI: 10.1134/S0026893308010214 |
0.73 |
|
2008 |
Baranova A, Younossi ZM. Adipokines and cytokines in non-alcoholic fatty liver disease. Authors' reply Alimentary Pharmacology & Therapeutics. 28: 267-268. DOI: 10.1111/J.1365-2036.2008.03724.X |
0.46 |
|
2008 |
Younossi Z, Baranova A, Stepanova M, Afendy A, Wheeler A, Hossain N, Bakshi A, Santini C, Sigua C, Chan J, Iverson A, Chang S. 766 A PANEL OF GENE EXPRESSION BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR) IN CHRONIC HEPATITIS C PATIENTS (CH-C) TREATED WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN Journal of Hepatology. 48: S286. DOI: 10.1016/S0168-8278(08)60768-0 |
0.312 |
|
2008 |
Younossi Z, Baranova A, Stepanova M, Schmidt S, Younossi I, Nader F, Santini C, Chan J, Chang S. 765 GENE EXPRESSION ASSOCIATED WITH ADCANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C) Journal of Hepatology. 48: S285-S286. DOI: 10.1016/S0168-8278(08)60767-9 |
0.331 |
|
2008 |
Younossi Z, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Afendy A, Rafiq N, Goodman Z, Chandhoke V, Baranova A. 31 VALIDATION OF A DIAGNOSTIC BIOMARKER PANEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) Journal of Hepatology. 48: S14-S15. DOI: 10.1016/S0168-8278(08)60033-1 |
0.788 |
|
2008 |
Younossi ZM, Baranova A, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, Srishord MK, Santini C, Chan J, Chang SP. S1904 Gene Expression Associated with Hepatic Steatosis in Patients with Chronic Hepatitis C (Ch-C) Genotype 1 Gastroenterology. 134: A-781. DOI: 10.1016/S0016-5085(08)63646-X |
0.345 |
|
2007 |
Baranova A, Schlauch K, Elariny H, Jarrar M, Bennett C, Nugent C, Gowder SJ, Younoszai Z, Collantes R, Chandhoke V, Younossi ZM. Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. Obesity Surgery. 17: 1111-8. PMID 17953248 DOI: 10.1007/S11695-007-9187-Y |
0.811 |
|
2007 |
Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, Goodman Z, Liotta LA, Petricoin EF, Younossi ZM. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology (Baltimore, Md.). 46: 166-72. PMID 17596878 DOI: 10.1002/Hep.21688 |
0.427 |
|
2007 |
Baranova A, Liotta L, Petricoin E, Younossi ZM. The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease. Clinics in Liver Disease. 11: 209-20, xi. PMID 17544980 DOI: 10.1016/J.Cld.2007.02.003 |
0.462 |
|
2007 |
Jarrar MH, Baranova A. PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. Journal of Cellular and Molecular Medicine. 11: 71-87. PMID 17367502 DOI: 10.1111/J.1582-4934.2007.00003.X |
0.714 |
|
2007 |
Baranova A, Randhawa M, Jarrar M, Younossi ZM. Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease. Expert Review of Molecular Diagnostics. 7: 195-205. PMID 17331066 DOI: 10.1586/14737159.7.2.195 |
0.812 |
|
2007 |
Jarrar M, Ranard B, Stepanova M, Nugent C, Elariny H, Bennett C, Collantes R, Goodman Z, Chandhoke V, Baranova A, Younossi Z. [718] HEPATIC MANIFESTATION OF METABOLIC SYNDROME (MS): NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SERUM ADIPOKINES Journal of Hepatology. 46: S271. DOI: 10.1016/S0168-8278(07)62316-2 |
0.785 |
|
2006 |
Baranova A, Gowder S, Naouar S, King S, Schlauch K, Jarrar M, Ding Y, Cook B, Chandhoke V, Christensen A. Expression profile of ovarian tumors: distinct signature of Sertoli-Leydig cell tumor. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 1963-72. PMID 17177833 DOI: 10.1111/J.1525-1438.2006.00732.X |
0.726 |
|
2006 |
Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obesity Surgery. 16: 1118-25. PMID 16989692 DOI: 10.1381/096089206778392149 |
0.442 |
|
2006 |
Collantes R, Baranova A, Schlauch K, Gowder S, Del Giacco L, Elarinyl H, Van Meter A, Afendy A, Ong J, Goodman Z, Chandhoke V, Younossi Z. 724 Gene expression in hepatic and white adipose tissues of patients with obesity-related non-alcoholic steatohepatitis (NASH) Journal of Hepatology. 44: S266. DOI: 10.1016/S0168-8278(06)80724-5 |
0.481 |
|
2005 |
Baranova A, Schlauch K, Gowder S, Collantes R, Chandhoke V, Younossi ZM. Microarray technology in the study of obesity and non-alcoholic fatty liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 1091-6. PMID 16343057 DOI: 10.1111/J.1478-3231.2005.01183.X |
0.423 |
|
2005 |
Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 42: 665-74. PMID 16116632 DOI: 10.1002/Hep.20838 |
0.479 |
|
2005 |
Baranova A, Collantes R, Gowder SJ, Elariny H, Schlauch K, Younoszai A, King S, Randhawa M, Pusulury S, Alsheddi T, Ong JP, Martin LM, Chandhoke V, Younossi ZM. Obesity-related differential gene expression in the visceral adipose tissue. Obesity Surgery. 15: 758-65. PMID 15978142 DOI: 10.1381/0960892054222876 |
0.773 |
|
Show low-probability matches. |